Augmenter of liver regeneration

Fibrogenesis and Tissue Repair

Volumn 5, Issue 1, 2012, Pages

  Gandhi, Chandrashekhar R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

ALR; GFER; Growth; Hepatocytes; Liver; Regeneration; Survival

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; CYTOCHROME C OXIDASE; DNA; G PROTEIN COUPLED RECEPTOR; HEPATOPOIETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; MYC PROTEIN; NITRIC OXIDE; ORNITHINE DECARBOXYLASE; SCATTER FACTOR; THIOL OXIDASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; CELL GROWTH; CELL NUCLEUS; CELL SURVIVAL; CHRONIC HEPATITIS; CYTOKINE PRODUCTION; CYTOSOL; DISEASE MARKER; DNA SYNTHESIS; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HUMAN; KUPFFER CELL; LIVER ATROPHY; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; LIVER REGENERATION; MITOCHONDRION; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW;

EID: 84870939214     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-10     Document Type: Review

References (95)

1. Higgins GM, Anderson RM. Experimental pathology of liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12:186-202.
2. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995, 9:1527-1536.
3. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997, 276:60-66. 10.1126/science.276.5309.60, 9082986.
4. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010, 176:2-13. 10.2353/ajpath.2010.090675, 2797862, 20019184.
5. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011, 26(Suppl 1):203-212. 3077908, 21199532.
6. McJunkin FA, Breuhaus HC. Homologous liver as a stimulus to hepatic regeneration. AMA Arch Pathol 1931, 12:900-908.
7. Teir H, Ravanti K. Mitotic activity and growth factors in the liver of the whole rat. Exp Cell Res 1953, 5:500-507. 10.1016/0014-4827(53)90236-5, 13117019.
8. Blomquist K. Growth stimulation in the liver and tumor development following intraperitoneal injections of liver homogenates in the rat. Acta Pathol Microbiol Scand 1957, 121:1-65.
9. Morley CG, Kingdon HS. The regulation of cell growth. I. Identification and partial characterization of a DNA synthesis stimulating factor from the serum of partially hepatectomized rats. Biochim Biophys Acta 1973, 308:260-275. 10.1016/0005-2787(73)90156-1, 4196223.
10. LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (HSS) from rat liver. J Physiol 1975, 248:273-284. 1309521, 1151784.
11. Starzl TE, Jones AF, Terblanche J, Usui S, Porter KA, Mazzoni G. Growth-stimulating factor in regenerating canine liver. Lancet 1979, 1:127-130. 2978530, 84151.
12. Terblanche J, Porter KA, Starzl TE, Moore J, Patzelt L, Hayashida N. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet 1980, 151:538-544. 2677963, 6998027.
13. van Hoorn-Hickman R, Kahn D, Green J, MacLeod HA, Terblanche J. Is there a regeneration stimulator substance in the effluent from perfused partially hepatectomized livers?. Hepatology 1981, 1:287-293. 10.1002/hep.1840010402, 7286908.
14. Fleig WE, Lehmann H, Wagner H, Hoss G, Ditschuneit H. Hepatic regenerative stimulator substance in the rabbit. Relation to liver regeneration after partial hepatectomy. J Hepatol 1986, 3:19-26. 10.1016/S0168-8278(86)80141-6, 3745882.
15. LaBrecque DR, Steele G, Fogerty S, Wilson M, Barton J. Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 1987, 7:100-106. 10.1002/hep.1840070121, 3804188.
16. Francavilla A, Ove P, Polimeno L, Coetzee M, Makowka L, Rose J, Van Thiel DH, Starzl TE. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 1987, 47:5600-5605. 3005282, 3664466.
17. Francavilla A, Barone M, Van Thiel DH, Mazzaferro V, Prelich J, Starzl TE. Further steps of HSS (hepatic stimulatory substance) purification. Dig Dis Sci 1991, 36:674-680. 10.1007/BF01297037, 2955430, 2022170.
18. Francavilla A, Hagiya M, Porter KA, Polimeno L, Ihara I, Starzl TE. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 1994, 20:747-757. 10.1002/hep.1840200328, 8076931.
19. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, Shimonishi M, Porter KA, Starzl TE. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994, 8142:8146. Correction in Proc Natl Acad Sci U S A 1995, 92:3076.
20. Giorda R, Hagiya M, Seki T, Shimonishi M, Sakai H, Michaelson J, Francavilla A, Starzl TE, Trucco M. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996, 2:97-108. 2230030, 8900538.
21. Gandhi CR, Kuddus R, Subbotin VM, Prelich J, Murase N, Rao AS, Nalesnik MA, Watkins SC, DeLeo A, Trucco M, Starzl TE. A fresh look at augmenter of liver regeneration in rats. Hepatology 1999, 29:1435-1445. 10.1002/hep.510290522, 2978975, 10216127.
22. Gandhi CR, Murase N, Starzl TE. Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat Kupffer cells. J Cell Physiol 2010, 222:365-373. 10.1002/jcp.21957, 3034370, 19859909.
23. Lisowsky T, Weinstat-Saslow DL, Barton N, Reeders ST, Schneider MC. A new human gene located in the PKD1 region of chromosome 16 is a functional homologue to ERV1 of yeast. Genomics 1995, 29:690-697. 10.1006/geno.1995.9950, 8575761.
24. Lisowsky T. Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast. Mol Gen Genet 1992, 232:58-64. 10.1007/BF00299137, 1552903.
25. Lisowsky T. Removal of an intron with unique 3' branch site creates an amino-terminal protein sequence directing the scERV1 gene product to mitochondria. Yeast 1996, 12:1501-1510. 10.1002/(SICI)1097-0061(199612)12:15<1501::AID-YEA40>3.0.CO;2-H, 8972573.
26. He F, Wu C, Tu Q, Xing G. Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 1993, 17:225-229. 10.1002/hep.1840170211, 8381383.
27. Wang G, Yang X, Zhang Y, Wang Q, Chen H, Wei H, Xing G, Xie L, Hu Z, Zhang C, Fang D, Wu C, He F. Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1. J Biol Chem 1999, 274:11469-11472. 10.1074/jbc.274.17.11469, 10206950.
28. Stein G, Lisowsky T. Functional comparison of the yeast scERV1 and scERV2 genes. Yeast 1998, 14:171-180. 10.1002/(SICI)1097-0061(19980130)14:2<171::AID-YEA209>3.0.CO;2-U, 9483805.
29. Hofhaus G, Lee JE, Tews I, Rosenberg B, Lisowsky T. The N-terminal cysteine pair of yeast sulfhydryl oxidase Erv1p is essential for in vivo activity and interacts with the primary redox centre. Eur J Biochem 2003, 270:1528-1535. 10.1046/j.1432-1033.2003.03519.x, 12654008.
30. Lee J, Hofhaus G, Lisowsky T. Erv1p from Saccharomyces cerevisiae is a FAD-linked sulfhydryl oxidase. FEBS Lett 2000, 477:62-66. 10.1016/S0014-5793(00)01767-1, 10899311.
31. Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, Schlitt HJ, Jauch KW, Weiss TS. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005, 47:57-66. 10.1111/j.1365-2559.2005.02172.x, 15982324.
32. Rose JP, Wu CK, Francavilla A, Prelich JG, Iacobellis A, Hagiya M, Rao AS, Starzl TE, Wang BC. Crystallization and preliminary crystallographic data for the augmenter of liver regeneration. Acta Crystallogr D: Biol Crystallogr 1997, 53:331-334.
33. Wu CK, Dailey TA, Dailey HA, Wang BC, Rose JP. The crystal structure of augmenter of liver regeneration: A mammalian FAD-dependent sulfhydryl oxidase. Protein Sci 2003, 12:1109-1118. 10.1110/ps.0238103, 2323880, 12717032.
34. Farrell SR, Thorpe C. Augmenter of liver regeneration: a flavin-dependent sulfhydryl oxidase with cytochrome c reductase activity. Biochemistry 2005, 44:1532-1541. 10.1021/bi0479555, 15683237.
35. Vitu E, Bentzur M, Lisowsky T, Kaiser CA, Fass D. Gain of function in an ERV/ALR sulfhydryl oxidase by molecular engineering of the shuttle disulfide. J Mol Biol 2006, 362:89-101. 10.1016/j.jmb.2006.06.070, 16893552.
36. Klissenbauer M, Winters S, Heinlein UA, Lisowsky T. Accumulation of the mitochondrial form of the sulphydryl oxidase Erv1p/Alrp during the early stages of spermatogenesis. J Exp Biol 2002, 205:1979-1986.
37. Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, Sun Y, Wei H, Yang X, Wu C, Chen J, Guan KL, Zhang C, Chen H, He F. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. FASEB J 2002, 16:90-92.
38. Tury A, Mairet-Coello G, Lisowsky T, Griffond B, Fellmann D. Expression of the sulfhydryl oxidase ALR (Augmenter of Liver Regeneration) in adult rat brain. Brain Res 2005, 1048:87-97. 10.1016/j.brainres.2005.04.050, 15916753.
39. Sevier CS, Cuozzo JW, Vala A, Aslund F, Kaiser CA. A flavoprotein oxidase defines a new endoplasmic reticulum pathway for biosynthetic disulphide bond formation. Nat Cell Biol 2001, 3:874-882. 10.1038/ncb1001-874, 11584268.
40. Lisowsky T. ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae. Curr Genet 1994, 26:15-20. 10.1007/BF00326299, 7954891.
41. Lange H, Lisowsky T, Gerber J, Mühlenhoff U, Kispal G, Lill R. An essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in the maturation of cytosolic Fe/S proteins. EMBO Rep 2001, 2:715-720. 10.1093/embo-reports/kve161, 1083998, 11493598.
42. Becher D, Kricke J, Stein G, Lisowsky T. A mutant for the yeast scERV1 gene displays a new defect in mitochondrial morphology and distribution. Yeast 1999, 15:1171-1181. 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T, 10487920.
43. Thirunavukkarasu C, Wang LF, Harvey SAK, Watkins SC, Chaillet JR, Starzl TE, Gandhi CR. Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatology 2008, 48:578-588.
44. Hofhaus G, Stein G, Polimeno L, Francavilla A, Lisowsky T. Highly divergent amino termini of the homologous human ALR and yeast scERV gene products define species differences in cellular localization. Eur J Cell Biol 1999, 78:349-356. 10.1016/S0171-9335(99)80069-7, 10384986.
45. Dayoub R, Thasler WE, Bosserhoff AK, Singer T, Jauch KW, Schlitt HJ, Weiss TS. Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem Biophys Res Commun 2006, 345:181-187. 10.1016/j.bbrc.2006.04.040, 16677602.
46. Li Y, Li M, Xing G, Hu Z, Wang Q, Dong C, Wei H, Fan G, Chen J, Yang X, Zhao S, Chen H, Guan K, Wu C, Zhang C, He F. Stimulation of the mitogen-activated protein kinase cascade and tyrosine phosphorylation of the epidermal growth factor receptor by hepatopoietin. J Biol Chem 2000, 275:37443-37447. 10.1074/jbc.M004373200, 10982794.
47. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379:557-560. 10.1038/379557a0, 8596637.
48. Zanella CL, Posada J, Tritton TR, Mossman BT. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res 1996, 56:5334-5338.
49. Ilowski M, Putz C, Weiss TS, Brand S, Jauch KW, Hengstler JG, Thasler WE. Augmenter of liver regeneration causes different kinetics of ERK1/2 and Akt/PKB phosphorylation than EGF and induces hepatocyte proliferation in an EGF receptor independent and liver specific manner. Biochem Biophys Res Commun 2010, 394:915-920. 10.1016/j.bbrc.2010.03.074, 20230786.
50. Thasler WE, Dayoub R, Mühlbauer M, Hellerbrand C, Singer T, Gräbe A, Jauch KW, Schlitt HJ, Weiss TS. Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration. J Pharmacol Exp Ther 2006, 316:822-829.
51. Nagoshi S, Fujiwara K. Putrescine as a comitogen of epidermal growth factor in rat liver growth. Hepatology 1994, 20:725-730. 10.1002/hep.1840200325, 8076929.
52. Higaki I, Matsui-Yuasa I, Hirohashi K, Kinoshita H, Otani S. The role of polyamines in growth factor induced DNA synthesis in cultured rat hepatocytes. Hepatogastroenterology 1999, 46:1874-1879.
53. Diehl AM, Abdo S, Brown N. Supplemental putrescine reverses ethanol-associated inhibition of liver regeneration. Hepatology 1990, 12:633-637. 10.1002/hep.1840120402, 2210666.
54. Luk GD. Essential role of polyamine metabolism in hepatic regeneration. Inhibition of deoxyribonucleic acid and protein synthesis and tissue regeneration by diuoromethylornithine in the rat. Can J Physiol Pharmacol 1986, 90:1261-1267.
55. Terakura M, Higaki I, Matsui-Yuasa I, Kinoshita H, Otani S. Polyamine metabolism in the rat liver after orthotopic liver transplantation. Biochim Biophys Acta 1995, 1245:207-214. 10.1016/0304-4165(95)00100-P, 7492579.
56. Fujiwara K, Nagoshi S. Biological activity of growth factors in vivo. Liver Growth and Repair 1998, 163-182. London: Chapman & Hall, Strain A, Diehl AM.
57. Levitchi M, Fradette C, Bleau AM, Michaud D, Kourylko O, Arcand M, Du SP. Signal transduction pathways implicated in the decrease in CYP1A1, 1A2 and 3A6 activity produced by serum from rabbits and humans with an inflammatory reaction. Biochem Pharmacol 2004, 68:573-582. 10.1016/j.bcp.2004.04.002, 15242823.
58. Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2 and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995, 22:1143-1153.
59. Donato MT, Gomez-Lechon MJ, Jover R, Nakamura T, Castell JV. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. J Pharmacol Exp Ther 1998, 284:760-767.
60. Morel Y, Barouki R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress: critical contribution of nuclear factor 1. J Biol Chem 1998, 273:26969-26976. 10.1074/jbc.273.41.26969, 9756946.
61. Tinel M, Berson A, Elkahwaji J, Cresteil T, Beaune P, Pessayre D. Downregulation of cytochromes P450 in growth-stimulated rat hepatocytes: role of c-Myc induction and impaired C/EBP binding to DNA. J Hepatol 2003, 39:171-178. 10.1016/S0168-8278(03)00238-1, 12873812.
62. Iber H, Chen Q, Cheng PY, Morgan ET. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-kappaB binding at the transcription start site. Arch Biochem Biophys 2000, 377:187-194. 10.1006/abbi.2000.1772, 10775459.
63. Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J 2002, 16:1799-1801.
64. Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P, Vilarem MJ. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 2000, 274:707-713. 10.1006/bbrc.2000.3219, 10924340.
65. Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR. Arch Biochem Biophys 1999, 369:11-23. 10.1006/abbi.1999.1351, 10462436.
66. Honkakoski P, Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 2000, 347:321-337. 10.1042/0264-6021:3470321, 1220963, 10749660.
67. Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, Pascussi JM. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 2004, 40:951-960.
68. Francavilla A, Vujanovic NL, Polimeno L, Azzarone A, Iacobellis A, Deleo A, Hagiya M, Whiteside TL, Starzl TE. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997, 25:411-415. 2993082, 9021955.
69. Vujanovic NL, Polimeno L, Azzarone A, Francavilla A, Chambers WH, Starzl TE, Herberman RB, Whiteside TL. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995, 154:6324-6338.
70. Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000, 35:112-119. 10.1007/s005350050023, 10680666.
71. Theocharis SE, Margeli AP, Agapitos EV, Mykoniatis MG, Kittas CN, Davaris PS. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats. Scand J Gastroenterol 1998, 33:656-663. 10.1080/00365529850171954, 9669640.
72. Zhang M, Song G, Minuk GY. Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofluoxacin on cirrhosis in the rat. Gastroenterology 1996, 110:1150-1155. 10.1053/gast.1996.v110.pm8613004, 8613004.
73. Ilowski M, Kleespies A, de Toni EN, Donabauer B, Jauch KW, Hengstler JG, Thasler WE. Augmenter of liver regeneration (ALR) protects human hepatocytes against apoptosis. Biochem Biophys Res Commun 2011, 404:148-152. 10.1016/j.bbrc.2010.11.083, 21108930.
74. Polimeno L, Pesetti B, Lisowsky T, Iannone F, Resta L, Giorgio F, Mallamaci R, Buttiglione M, Santovito D, Vitiello F, Mancini ME, Francavilla A. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res 2009, 43:865-875. 10.1080/10715760903100125, 19629817.
75. Coppock DL, Cina-Poppe D, Gilleran S. The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics 1998, 54:460-468. 10.1006/geno.1998.5605, 9878249.
76. Hoober KL, Thorpe C. Egg white sulfhydryl oxidase: Kinetic mechanism of the catalysis of disulfide bond formation. Biochemistry 1999, 38:3211-3217. 10.1021/bi9820816, 10074377.
77. Hoober KL, Glynn NM, Burnside J, Coppock DL, Thorpe C. Homology between egg white sulfhydryl oxidase and quiescin Q6 defines a new class of flavin-linked sulfhydryl oxidases. J Biol Chem 1999, 274:31759-31762. 10.1074/jbc.274.45.31759, 10542195.
78. Hoober KL, Thorpe C. Flavin-dependent sulfhydryl oxidases in protein disulfide bond formation. Methods Enzymol 2002, 348:30-34.
79. Thorpe C, Hoober K, Raje S, Glynn N, Burnside J, Turi G, Coppock D. Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys 2002, 405:1-12. 10.1016/S0003-9861(02)00337-5, 12176051.
80. Gerber J, Mühlenhoff U, Hofhaus G, Lill R, Lisowsky T. Yeast ERV2p is the first microsomal FAD-linked sulfhydryl oxidase of the Erv1p/Alrp protein family. J Biol Chem 2001, 276:23486-23491. 10.1074/jbc.M100134200, 11313344.
81. Lisowsky T, Lee JE, Polimeno L, Francavilla A, Hofhaus G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis 2001, 33:173-180. 10.1016/S1590-8658(01)80074-8, 11346147.
82. Gross E, Sevier CS, Vala A, Kaiser CA, Fass D. A new FAD-binding fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p. Nat Struct Biol 2002, 9:61-67. 10.1038/nsb740, 11740506.
83. Maret W. Cellular zinc and redox States converge in the metallothionein/thionein pair. J Nutr 2003, 133:1460S-1462S.
84. Maret W, Vallee BL. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc Natl Acad Sci USA 1998, 95:3478-3482. 10.1073/pnas.95.7.3478, 19861, 9520391.
85. Lu H, Allen S, Wardleworth L, Savory P, Tokatlidis K. Functional TIM10 chaperone assembly is redox-regulated in vivo. J Biol Chem 2004, 279:18952-18958. 10.1074/jbc.M313045200, 14973127.
86. Lutz T, Neupert W, Herrmann JM. Import of small Tim proteins into the mitochondrial intermembrane space. EMBO J 2003, 22:4400-4408. 10.1093/emboj/cdg421, 202364, 12941692.
87. Field LS, Furukawa Y, O'Halloran TV, Culotta VC. Factors controlling the uptake of yeast copper/zinc superoxide dismutase into mitochondria. J Biol Chem 2003, 278:28052-28059. 10.1074/jbc.M304296200, 12748182.
88. Li Y, Farooq M, Sheng D, Chandramouli C, Lan T, Mahajan NK, Kini RM, Hong Y, Lisowsky T, Ge R. Augmenter of liver regeneration (alr) promotes liver outgrowth during zebrafish hepatogenesis. PLoS One 2012, 7:e30835. 10.1371/journal.pone.0030835, 3266923, 22292055.
89. Allen S, Balabanidou V, Sideris DP, Lisowsky T, Tokatlidis K. Erv1 mediates the Mia40-dependent protein import pathway and provides a functional link to the respiratory chain by shuttling electrons to cytochrome c. J Mol Biol 2005, 353:937-944. 10.1016/j.jmb.2005.08.049, 16185707.
90. Diekert K, de Kroon AI, Ahting U, Niggemeyer B, Neupert W, de Kruijff B, Lill R. Apocytochrome c requires the TOM complex for translocation across the mitochondrial outer membrane. EMBO J 2001, 20:5626-5635. 10.1093/emboj/20.20.5626, 125676, 11598006.
91. Wiedemann N, Kozjak V, Prinz T, Ryan MT, Meisinger C, Pfanner N, Truscott KN. Biogenesis of yeast mitochondrial cytochrome c: a unique relationship to the TOM machinery. J Mol Biol 2003, 327:465-474. 10.1016/S0022-2836(03)00118-9, 12628251.
92. Gandhi CR, Murase N, Subbotin VM, Uemura T, Nalesnik M, Demetris AJ, Fung JJ, Starzl TE. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol 2002, 37:340-348. 10.1016/S0168-8278(02)00165-4, 2975525, 12175629.
93. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999, 19:129-140. 10.1055/s-2007-1007105, 10422196.
94. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001, 21:397-416. 10.1055/s-2001-17554, 11586468.
95. Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis 2010, 30:402-410. 10.1055/s-0030-1267540, 3071245, 20960379.